Today: 2 February 2026
Subscribe
Browse Category

NASDAQ:INDP News 24 December 2025

Indaptus Therapeutics (INDP) Stock in Focus on Dec. 24, 2025: $6M Financing, Leadership Reset, and the Dilution Question

Indaptus Therapeutics (INDP) Stock in Focus on Dec. 24, 2025: $6M Financing, Leadership Reset, and the Dilution Question

Indaptus Therapeutics, Inc. (NASDAQ: INDP) is getting unusual attention heading into December 24, 2025, after a late-December SEC filing laid out a $6.0 million preferred-stock financing, a boardroom reshuffle, and a new co-CEO / chairman appointment—a mix that can ignite short-term trading interest while also forcing investors to re-run the long-term share-count math. SEC The key tension is straightforward: the…
24 December 2025
·····

Stock Market Today

  • Sportradar Group (SRAD) Share Price Weakness Highlights Valuation Debate
    February 2, 2026, 3:29 PM EST. Sportradar Group (NasdaqGS:SRAD) has posted sharp share price declines, with a 22.34% drop over one month and 29.20% over three months, despite a positive three-year shareholder return of 38.88%. Trading at $18.11, well below the $32.61 narrative fair value based on earnings and cash flow forecasts, the stock faces questions about whether recent weakness offers a buying opportunity or reflects market skepticism over growth prospects. Increased demand for real-time sports data and premium products is driving revenue of €1.23 billion and net income near €95 million, supporting optimistic forecasts. However, Sportradar's high price-to-earnings ratio of 48.1x exceeds peers and industry averages, indicating valuation risk amid market sentiment shifts. Investors weigh growth potential against competition and contract renewal uncertainties.
Go toTop